When it comes to cancer, it’s not uncommon to hear: “We had the same diagnosis—why did their recovery go smoothly, while mine has been so difficult?” The answer lies in the complex, highly individualized nature of cancer and human biology.
In the process of cancer care, more and more patients are seeking additional methods, alongside conventional medical treatments, to help boost energy levels and adjust their physical and mental state. Whether through diet, nutritional supplementation, or lifestyle changes, many people hope to find a method that aligns more closely with their individual needs throughout their care journey.
In the process of cancer care, formulating a precise and personalized care plan has always been a major challenge. Traditional imaging and tumor marker tests are commonly used but often fail to comprehensively reflect the real-time dynamics and microscopic biological characteristics of tumors. With rapid advancements in liquid biopsy and genetic testing technologies, RGCC’s Onconomics Plus integrated analysis provides richer and more accurate data to support personalized care decisions, enabling healthcare teams to adjust care plans in a timely manner and ultimately improve patient prognosis and quality of life.
Immunotherapy has become a breakthrough approach in cancer care, offering new hope for patients by utilizing the body’s immune system to fight cancer. Unlike traditional chemotherapy or radiotherapy, immunotherapy focuses on enhancing the immune system’s ability to recognize and destroy cancer cells. This article will explore the basic principles of immunotherapy, various treatment methods, and its application in cancer management, as well as how testing can help assess the status of the immune system for more accurate treatment decisions.
RGCC Immune-Frame is an advanced immune analysis technology developed by RGCC to provide in-depth immune function testing and support for personalized medicine and cancer care. The technology combines precise scientific methods to conduct a comprehensive assessment of the patient’s immune system to help medical professionals develop more effective care plans.
Onconomics Extract Plus is an innovative blood testing technology introduced by RGCC (The Research Genetic Cancer Center) designed to provide early cancer detection, treatment monitoring, and personalized care by analyzing metabolites and biomarkers in the blood. This test identifies characteristic substances produced by tumor cells during metabolic processes, offering real-time diagnostic information and personalized care guidance for physicians. The Onconomics Extract Plus test enables a more precise understanding of cancer progression, treatment responses, and patient care.